nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—Hoarseness—Varenicline—nicotine dependence	0.0498	0.062	CcSEcCtD
Tiotropium—Throat irritation—Varenicline—nicotine dependence	0.0434	0.054	CcSEcCtD
Tiotropium—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0325	0.0404	CcSEcCtD
Tiotropium—Laryngeal pain—Varenicline—nicotine dependence	0.0322	0.04	CcSEcCtD
Tiotropium—Intestinal obstruction—Varenicline—nicotine dependence	0.0322	0.04	CcSEcCtD
Tiotropium—Gingivitis—Varenicline—nicotine dependence	0.0279	0.0347	CcSEcCtD
Tiotropium—Dysphonia—Varenicline—nicotine dependence	0.0266	0.0332	CcSEcCtD
Tiotropium—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0243	0.0302	CcSEcCtD
Tiotropium—Influenza like illness—Varenicline—nicotine dependence	0.0213	0.0265	CcSEcCtD
Tiotropium—Mouth ulceration—Varenicline—nicotine dependence	0.0198	0.0247	CcSEcCtD
Tiotropium—Arthritis—Varenicline—nicotine dependence	0.0164	0.0204	CcSEcCtD
Tiotropium—Urinary retention—Varenicline—nicotine dependence	0.0151	0.0188	CcSEcCtD
Tiotropium—Dry skin—Varenicline—nicotine dependence	0.0146	0.0181	CcSEcCtD
Tiotropium—Dysphagia—Varenicline—nicotine dependence	0.0138	0.0171	CcSEcCtD
Tiotropium—Angina pectoris—Varenicline—nicotine dependence	0.0134	0.0167	CcSEcCtD
Tiotropium—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0125	0.0636	CbGpPWpGaD
Tiotropium—Hyperglycaemia—Varenicline—nicotine dependence	0.0124	0.0154	CcSEcCtD
Tiotropium—Stomatitis—Varenicline—nicotine dependence	0.012	0.0149	CcSEcCtD
Tiotropium—Epistaxis—Varenicline—nicotine dependence	0.0116	0.0144	CcSEcCtD
Tiotropium—Sinusitis—Varenicline—nicotine dependence	0.0115	0.0143	CcSEcCtD
Tiotropium—Urinary tract disorder—Varenicline—nicotine dependence	0.0109	0.0135	CcSEcCtD
Tiotropium—Oedema peripheral—Varenicline—nicotine dependence	0.0108	0.0135	CcSEcCtD
Tiotropium—Connective tissue disorder—Varenicline—nicotine dependence	0.0108	0.0135	CcSEcCtD
Tiotropium—Urethral disorder—Varenicline—nicotine dependence	0.0108	0.0134	CcSEcCtD
Tiotropium—Visual impairment—Varenicline—nicotine dependence	0.0106	0.0132	CcSEcCtD
Tiotropium—Eye disorder—Varenicline—nicotine dependence	0.0103	0.0128	CcSEcCtD
Tiotropium—Angiopathy—Varenicline—nicotine dependence	0.00999	0.0124	CcSEcCtD
Tiotropium—Immune system disorder—Varenicline—nicotine dependence	0.00995	0.0124	CcSEcCtD
Tiotropium—Mediastinal disorder—Varenicline—nicotine dependence	0.00992	0.0123	CcSEcCtD
Tiotropium—Arrhythmia—Varenicline—nicotine dependence	0.00984	0.0122	CcSEcCtD
Tiotropium—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00973	0.0496	CbGpPWpGaD
Tiotropium—Mental disorder—Varenicline—nicotine dependence	0.00965	0.012	CcSEcCtD
Tiotropium—Malnutrition—Varenicline—nicotine dependence	0.00958	0.0119	CcSEcCtD
Tiotropium—Back pain—Varenicline—nicotine dependence	0.00927	0.0115	CcSEcCtD
Tiotropium—Vision blurred—Varenicline—nicotine dependence	0.00903	0.0112	CcSEcCtD
Tiotropium—Angioedema—Varenicline—nicotine dependence	0.00876	0.0109	CcSEcCtD
Tiotropium—Syncope—Varenicline—nicotine dependence	0.0086	0.0107	CcSEcCtD
Tiotropium—Palpitations—Varenicline—nicotine dependence	0.00847	0.0105	CcSEcCtD
Tiotropium—Loss of consciousness—Varenicline—nicotine dependence	0.00842	0.0105	CcSEcCtD
Tiotropium—Cough—Varenicline—nicotine dependence	0.00836	0.0104	CcSEcCtD
Tiotropium—Hypertension—Varenicline—nicotine dependence	0.00828	0.0103	CcSEcCtD
Tiotropium—Chest pain—Varenicline—nicotine dependence	0.00816	0.0102	CcSEcCtD
Tiotropium—Arthralgia—Varenicline—nicotine dependence	0.00816	0.0102	CcSEcCtD
Tiotropium—Myalgia—Varenicline—nicotine dependence	0.00816	0.0102	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0081	0.0101	CcSEcCtD
Tiotropium—Dry mouth—Varenicline—nicotine dependence	0.00798	0.00993	CcSEcCtD
Tiotropium—Oedema—Varenicline—nicotine dependence	0.00782	0.00973	CcSEcCtD
Tiotropium—Infection—Varenicline—nicotine dependence	0.00777	0.00967	CcSEcCtD
Tiotropium—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00773	0.0394	CbGpPWpGaD
Tiotropium—Shock—Varenicline—nicotine dependence	0.0077	0.00957	CcSEcCtD
Tiotropium—Nervous system disorder—Varenicline—nicotine dependence	0.00767	0.00954	CcSEcCtD
Tiotropium—Tachycardia—Varenicline—nicotine dependence	0.00763	0.0095	CcSEcCtD
Tiotropium—Skin disorder—Varenicline—nicotine dependence	0.0076	0.00945	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00713	0.00887	CcSEcCtD
Tiotropium—Insomnia—Varenicline—nicotine dependence	0.00708	0.0088	CcSEcCtD
Tiotropium—Dyspepsia—Varenicline—nicotine dependence	0.00689	0.00857	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00675	0.0084	CcSEcCtD
Tiotropium—Constipation—Varenicline—nicotine dependence	0.00669	0.00832	CcSEcCtD
Tiotropium—Gastrointestinal pain—Varenicline—nicotine dependence	0.0064	0.00796	CcSEcCtD
Tiotropium—Urticaria—Varenicline—nicotine dependence	0.00621	0.00773	CcSEcCtD
Tiotropium—Abdominal pain—Varenicline—nicotine dependence	0.00618	0.00769	CcSEcCtD
Tiotropium—CHRM5—Monoamine GPCRs—DRD2—nicotine dependence	0.00584	0.0298	CbGpPWpGaD
Tiotropium—Hypersensitivity—Varenicline—nicotine dependence	0.00576	0.00717	CcSEcCtD
Tiotropium—Pruritus—Varenicline—nicotine dependence	0.00553	0.00688	CcSEcCtD
Tiotropium—Dizziness—Varenicline—nicotine dependence	0.00517	0.00643	CcSEcCtD
Tiotropium—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00506	0.0258	CbGpPWpGaD
Tiotropium—Vomiting—Varenicline—nicotine dependence	0.00497	0.00619	CcSEcCtD
Tiotropium—Rash—Varenicline—nicotine dependence	0.00493	0.00614	CcSEcCtD
Tiotropium—Dermatitis—Varenicline—nicotine dependence	0.00493	0.00613	CcSEcCtD
Tiotropium—CHRM5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00491	0.025	CbGpPWpGaD
Tiotropium—Headache—Varenicline—nicotine dependence	0.0049	0.0061	CcSEcCtD
Tiotropium—Nausea—Varenicline—nicotine dependence	0.00465	0.00578	CcSEcCtD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0045	0.023	CbGpPWpGaD
Tiotropium—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00411	0.021	CbGpPWpGaD
Tiotropium—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.0041	0.0209	CbGpPWpGaD
Tiotropium—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00406	0.0207	CbGpPWpGaD
Tiotropium—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00346	0.0176	CbGpPWpGaD
Tiotropium—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00344	0.0176	CbGpPWpGaD
Tiotropium—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00341	0.0174	CbGpPWpGaD
Tiotropium—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00321	0.0164	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00317	0.0162	CbGpPWpGaD
Tiotropium—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00317	0.0162	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00316	0.0161	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00313	0.016	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.0028	0.0143	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00277	0.0141	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00269	0.0137	CbGpPWpGaD
Tiotropium—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0026	0.0133	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—TAS2R16—nicotine dependence	0.00241	0.0123	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00237	0.0121	CbGpPWpGaD
Tiotropium—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0021	0.0107	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00207	0.0106	CbGpPWpGaD
Tiotropium—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00207	0.0106	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00197	0.0101	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00197	0.01	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00195	0.00993	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00189	0.00964	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00188	0.00961	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00187	0.00952	CbGpPWpGaD
Tiotropium—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0017	0.00868	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.0017	0.00866	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00169	0.00863	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00168	0.00855	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00158	0.00808	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00156	0.00795	CbGpPWpGaD
Tiotropium—CHRM5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00156	0.00795	CbGpPWpGaD
Tiotropium—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00147	0.00748	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00144	0.00734	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00138	0.00705	CbGpPWpGaD
Tiotropium—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00136	0.00696	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00136	0.00695	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00134	0.00681	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00131	0.00668	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—TAS2R16—nicotine dependence	0.00124	0.00631	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00117	0.00595	CbGpPWpGaD
Tiotropium—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00113	0.00575	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0011	0.0056	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00109	0.00558	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00108	0.00552	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—FGD1—nicotine dependence	0.00107	0.00545	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—OPRM1—nicotine dependence	0.00102	0.00519	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—FGD1—nicotine dependence	0.000971	0.00495	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000969	0.00494	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000965	0.00492	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00096	0.00489	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000959	0.00489	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000957	0.00488	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000947	0.00483	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00094	0.00479	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000937	0.00478	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000928	0.00473	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000904	0.00461	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000892	0.00455	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000872	0.00444	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000869	0.00443	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00086	0.00439	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000844	0.0043	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000793	0.00405	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000791	0.00403	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000783	0.00399	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000753	0.00384	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000751	0.00383	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000743	0.00379	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.000735	0.00375	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.000731	0.00373	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000716	0.00365	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000714	0.00364	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000707	0.0036	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000684	0.00349	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000682	0.00348	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00068	0.00347	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000678	0.00346	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000675	0.00344	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000671	0.00342	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000575	0.00293	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—FGD1—nicotine dependence	0.000574	0.00293	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	0.000522	0.00266	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000518	0.00264	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000516	0.00263	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000515	0.00263	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000513	0.00262	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000511	0.00261	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000508	0.00259	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	0.000507	0.00258	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	0.000415	0.00212	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000405	0.00206	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000404	0.00206	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000403	0.00206	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000403	0.00205	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000399	0.00204	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000399	0.00203	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000396	0.00202	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	0.000377	0.00192	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000367	0.00187	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000366	0.00187	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000363	0.00185	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—WASF2—nicotine dependence	0.000357	0.00182	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000357	0.00182	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000356	0.00181	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000352	0.0018	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—WASF1—nicotine dependence	0.000342	0.00175	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	0.000308	0.00157	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000293	0.00149	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000292	0.00149	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000289	0.00147	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000266	0.00135	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000265	0.00135	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000262	0.00134	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000251	0.00128	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000251	0.00128	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000248	0.00127	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000241	0.00123	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.00024	0.00123	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000238	0.00121	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000236	0.00121	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DRD2—nicotine dependence	0.000223	0.00114	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000217	0.00111	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000216	0.0011	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000214	0.00109	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000157	0.0008	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000156	0.000798	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000155	0.00079	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000155	0.000789	CbGpPWpGaD
